Bartlett & Co Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $84.6M | Sell |
182,938
-11,431
| -6% | -$6.2M | 1.08% | 26 |
|
|
2025
Q4 | $113M | Buy |
194,369
+2,109
| +1% | +$1.19M | 1.47% | 18 |
|
|
2025
Q3 | $93.3M | Buy |
192,260
+1,396
| +0.7% | +$650K | 1.24% | 21 |
|
|
2025
Q2 | $77.5M | Buy |
190,864
+912
| +0.5% | +$381K | 1.08% | 26 |
|
|
2025
Q1 | $94.6M | Buy |
189,952
+9,989
| +6% | +$5.41M | 1.39% | 18 |
|
|
2024
Q4 | $93.7M | Buy |
179,963
+79
| +0% | +$43.4K | 1.36% | 19 |
|
|
2024
Q3 | $111M | Buy |
179,884
+913
| +0.5% | +$540K | 1.6% | 15 |
|
|
2024
Q2 | $99M | Buy |
178,971
+2,033
| +1% | +$1.16M | 1.5% | 16 |
|
|
2024
Q1 | $103M | Buy |
176,938
+3,053
| +2% | +$1.71M | 1.58% | 17 |
|
|
2023
Q4 | $92.7M | Buy |
173,885
+3,541
| +2% | +$1.71M | 1.51% | 17 |
|
|
2023
Q3 | $86.3M | Buy |
170,344
+5,234
| +3% | +$2.79M | 1.55% | 16 |
|
|
2023
Q2 | $86.2M | Buy |
165,110
+23,369
| +16% | +$12.6M | 1.49% | 16 |
|
|
2023
Q1 | $81.7M | Buy |
141,741
+951
| +0.7% | +$536K | 1.58% | 15 |
|
|
2022
Q4 | $77.6M | Buy |
140,790
+7,101
| +5% | +$3.76M | 1.56% | 15 |
|
|
2022
Q3 | $67.8M | Sell |
133,689
-17
| -0% | -$9.51K | 1.46% | 19 |
|
|
2022
Q2 | $72.7M | Sell |
133,706
-3,580
| -3% | -$1.97M | 1.47% | 15 |
|
|
2022
Q1 | $81.1M | Buy |
137,286
+3,490
| +3% | +$2M | 1.42% | 17 |
|
|
2021
Q4 | $89.3M | Sell |
133,796
-543
| -0.4% | -$339K | 1.51% | 15 |
|
|
2021
Q3 | $76.8M | Sell |
134,339
-1,606
| -1% | -$881K | 1.46% | 17 |
|
|
2021
Q2 | $68.6M | Buy |
135,945
+106
| +0.1% | +$50K | 1.31% | 20 |
|
|
2021
Q1 | $62M | Sell |
135,839
-2,460
| -2% | -$1.17M | 1.25% | 22 |
|
|
2020
Q4 | $64.4M | Sell |
138,299
-152
| -0.1% | -$71.3K | 1.37% | 17 |
|
|
2020
Q3 | $61.2M | Sell |
138,451
-132
| -0.1% | -$54.5K | 1.43% | 16 |
|
|
2020
Q2 | $50.2M | Sell |
138,583
-1,069
| -0.8% | -$358K | 1.31% | 19 |
|
|
2020
Q1 | $39.6M | Sell |
139,652
-717
| -0.5% | -$226K | 1.21% | 25 |
|
|
2019
Q4 | $45.6M | Buy |
140,369
+625
| +0.4% | +$190K | 1.11% | 25 |
|
|
2019
Q3 | $40.7M | Buy |
139,744
+85,857
| +159% | +$24.6M | 1.07% | 25 |
|
|
2019
Q2 | $15.8M | Buy |
53,887
+52,841
| +5,052% | +$14.6M | 0.59% | 59 |
|
|
2019
Q1 | $287K | Buy |
1,046
+78
| +8% | +$19.4K | 0.01% | 232 |
|
|
2018
Q4 | $217K | Sell |
968
-35
| -3% | -$8.21K | 0.01% | 246 |
|
|
2018
Q3 | $245K | Hold |
1,003
| – | – | 0.01% | 241 |
|
|
2018
Q2 | $208K | Buy |
1,003
+200
| +25% | +$42.5K | 0.01% | 250 |
|
|
2018
Q1 | $166K | Buy |
+803
| New | +$169K | 0.01% | 266 |
|
Other funds holding TMO
VCM
Bartlett & Co Wealth Management's TMO Position: Q1 2026 in Review
Bartlett & Co Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 5.9% in Q1 2026, selling an estimated $6.2M and leaving 182,938 shares worth $84.6M. The position accounts for 1.08% of the portfolio, ranked #26.
Bartlett & Co Wealth Management first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $113M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Bartlett & Co Wealth Management held 182,938 shares of Thermo Fisher Scientific worth $84.6M as of Q1 2026.
- Bartlett & Co Wealth Management sold 11,431 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.2M.
- Thermo Fisher Scientific made up 1.08% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #26 holding.
- Bartlett & Co Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Bartlett & Co Wealth Management's Thermo Fisher Scientific position peaked at $113M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.